HALO logo
halo search icon
Forte Biosciences Inc.
Forte Biosciences Inc.
FBRX · NAS

Forte Biosciences Inc.

US$20.31

Price Arrow0.24 (1.20%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEMA 125 BreakdownHALO AllHALO Consensus ValueHammer Bearish (Realtime)Near Support+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Forte Biosciences Inc. Overview

FBRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About FBRX

icon

Telephone

1.310.618.6994

icon

Address

Building 6, 3060 Pegasus Park Drive, Dallas, TX 75247

Description

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

FBRX Price Chart

Key Stats

Market Cap

US$393.28M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7 - 35.8

Trade Value (12mth)

US$994,991.00

1 week

-13.15%

1 month

-38.89%

YTD

-14.99%

1 year

182.28%

All time high

6732.30

Key Fundamentals

EPS 3 yr Growth

-76.40%

EBITDA Margin

0.00%

Operating Cashflow

-$51m

Free Cash Flow Return

-89.70%

ROIC

-122.30%

Interest Coverage

0.00

Quick Ratio

3.90

Other Data

Shares Outstanding (Fully Diluted)

18m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

FBRX Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
11 May 26
11 May 26

FBRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-24.92-12.17-4.71locklocklock
EPS (Fully Diluted)
$locklocklocklock-24.92-12.17-4.71locklocklock
Growth
%locklocklocklock-24.951.261.3locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Forte Biosciences Inc. (FBRX:NAS)?
Halo FAQ
The current share price of Forte Biosciences Inc. (FBRX:NAS) is USD$20.31.
What is the 52-week high share price for Forte Biosciences Inc. (FBRX:NAS)?
Halo FAQ
The 52-week high share price for Forte Biosciences Inc. (FBRX:NAS) is USD$35.80.
What is the 52-week low share price for Forte Biosciences Inc. (FBRX:NAS)?
Halo FAQ
The 52-week low share price for Forte Biosciences Inc. (FBRX:NAS) is USD$7.00.
What is the dividend yield for Forte Biosciences Inc. (FBRX:NAS)?
Halo FAQ
Forte Biosciences Inc. (FBRX:NAS) does not pay a dividend.
What was Forte Biosciences Inc. (FBRX:NAS) last dividend payment?
Halo FAQ
Forte Biosciences Inc. (FBRX:NAS) does not pay a dividend.
What is the franking level for Forte Biosciences Inc. (FBRX:NAS)?
Halo FAQ
Forte Biosciences Inc. (FBRX:NAS) has a franking level of 0.00%.
In which sector is Forte Biosciences Inc. (FBRX:NAS) classified?
Halo FAQ
Forte Biosciences Inc. (FBRX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.